Herbas VPB

Print
EN | LT
LT - COMPOSITION COMPRISING METHYLPHENIDATE AND ONDANSETRON FOR USE IN SUBSTANCE-RELATED DISORDERS
EN - COMPOSITION COMPRISING METHYLPHENIDATE AND ONDANSETRON FOR USE IN SUBSTANCE-RELATED DISORDERS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/445 (2006.01)
A61K 9/20 (2013.01)
A61K 9/20 (2006.01)
A61K 48/00 (2013.01)
A61K 9/48 (2013.01)
A61K 9/48 (2006.01)
A61K 45/06 (2013.01)
A61K 45/06 (2006.01)
A61P 1/14 (2006.01)
A61K 31/48 (2013.01)
A61K 31/517 (2006.01)
A61K 31/517 (2013.01)
A61K 31/4178 (2006.01)
A61K 31/4178 (2013.01)
A61K 48/00 (2006.01)
A61K 31/4458 (2013.01)
A61K 31/48 (2006.01)
A61P 1/14 (2018.01)
A61P 17/02 (2018.01)
A61P 3/04 (2006.01)
A61P 17/14 (2018.01)
A61P 17/02 (2006.01)
A61P 25/00 (2018.01)
A61K 31/4458 (2006.01)
A61P 17/14 (2006.01)
A61P 25/14 (2018.01)
A61P 25/00 (2006.01)
A61P 25/18 (2018.01)
A61P 25/30 (2006.01)
A61P 25/22 (2018.01)
A61P 25/32 (2006.01)
A61P 25/30 (2018.01)
A61P 25/36 (2006.01)
A61P 25/32 (2018.01)
A61P 25/14 (2006.01)
A61P 25/34 (2018.01)
A61P 43/00 (2006.01)
A61P 25/36 (2018.01)
A61P 3/04 (2018.01)
A61P 43/00 (2018.01)
European patent
(11) Number of the document 3251699
(13) Kind of document T
(96) European patent application number 16743696.3
Date of filing the European patent application 2016-01-28
(97) Date of publication of the European application 2017-12-06
(45) Date of publication and mention of the grant of the patent 2024-04-17
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/KR2016/000903
Date 2016-01-28
PCT application publication
(87) Number WO 2016/122218
Date 2016-08-04
Priority applications
(30) Number Date Country code
201562108616 P 2015-01-28 US
Inventors
(72)
LEE, Tong Hyon , US
Grantee
(73) Duke University , 2812 Erwin Road, Suite 306 P.O. Box 90083, Durham, North Carolina 27705, US
Title
(54) COMPOSITION COMPRISING METHYLPHENIDATE AND ONDANSETRON FOR USE IN SUBSTANCE-RELATED DISORDERS
  COMPOSITION COMPRISING METHYLPHENIDATE AND ONDANSETRON FOR USE IN SUBSTANCE-RELATED DISORDERS